US 9266856
AMPK—activating heterocyclic compounds and methods for using the same
granted A61PA61P1/04A61P1/14
Quick answer
US patent 9266856 (AMPK—activating heterocyclic compounds and methods for using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P1/04, A61P1/14, A61P1/16, A61P1/18